Asparaginase erwinia chrysanthemi recombinant-rywn (Intramuscular)

Medically reviewed by Drugs.com. Last updated on Nov 26, 2021.

Commonly used brand name(s)

In the U.S.

• Rylaze

Available Dosage Forms:

• Solution

Therapeutic Class: Antineoplastic Agent

Pharmacologic Class: Asparaginase Erwinia Chrysanthemi Recombinant

Uses for asparaginase erwinia chrysanthemi recombinant-rywn

Asparaginase Erwinia chrysanthemi recombinant-rywn is used together with other cancer medicines to treat certain types of blood cancer called acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL). Asparaginase erwinia chrysanthemi recombinant-rywn is used in patients who have had an allergic reaction to E. coli-derived asparaginase.

Asparaginase Erwinia chrysanthemi recombinant-rywn belongs to the group of medicines known as antineoplastic agents. It interferes with the growth of the cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by asparaginase erwinia chrysanthemi recombinant-rywn, other effects will also occur. Some of these may be serious and must be reported to your doctor.

Before you begin treatment with Rylaze™, you and your doctor should talk about the benefits of asparaginase erwinia chrysanthemi recombinant-rywn as well as the risks of using it.

Asparaginase erwinia chrysanthemi recombinant-rywn is to be given only by or under the direct supervision of your doctor.

Before using asparaginase erwinia chrysanthemi recombinant-rywn

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For asparaginase erwinia chrysanthemi recombinant-rywn, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to asparaginase erwinia chrysanthemi recombinant-rywn or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of Rylaze™ in children younger than 1 month of age. Safety and efficacy have not been established.

Geriatric

Appropriate studies have not been performed on the relationship of age to the effects of Rylaze™ in the geriatric population. Safety and efficacy have not been established.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with food/tobacco/alcohol

Certain medicines should not be used at or around the time of eating food or eating certain ...